Vontobel Holding Ltd. Seagen Inc. Transaction History

Vontobel Holding Ltd.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$191.51 - $216.16 $5,362 - $6,052	28 Added 0.67%	4,214 $894,000
Q2 2023 Jul 24, 2023	SELL	$187.64 - $206.25 $320,113 - $351,862	-1,706 Reduced 28.95%	4,186 $805,000
Q1 2023 Apr 12, 2023	BUY	$127.59 - $203.08 $194,957 - $310,306	1,528 Added 35.01%	5,892 $1.19 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $216,195 - $256,351	1,842 Added 73.04%	4,364 $560,000
Q3 2022 Nov 04, 2022	SELL	$135.27 - $180.11 $37,063 - $49,350	-274 Reduced 9.8%	2,522 $342,000
Q2 2022 Jul 27, 2022	BUY	$108.81 - $179.33 $46,135 - $76,035	424 Added 17.88%	2,796 $501,000
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $144,728 - $190,998	-1,210 Reduced 33.78%	2,372 $336,000
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $311,230 - $416,647	-2,183 Reduced 37.87%	3,582 $563,000
Q3 2021 Oct 29, 2021	BUY	$142.45 - $169.82 $53,276 - $63,512	374 Added 6.94%	5,765 $979,000
Q2 2021 Aug 06, 2021	BUY	$135.08 - $161.1 $14,588 - $17,398	108 Added 2.04%	5,391 $855,000
Q1 2021 May 11, 2021	BUY	$137.51 - $190.8 $194,301 - $269,600	1,413 Added 36.51%	5,283 $734,000
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $637,118 - $820,169	3,870 New	3,870 $686,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.